Monday, April 6, 2026
Business

Ghana Legalizes Cannabis Cultivation for Industrial and Medicinal Use, Initiates Licensing for Companies

Ghana has officially permitted the cultivation of cannabis for industrial and medicinal purposes following parliamentary approval. The government is now set to begin the licensing process for companies seeking to engage in regulated cannabis production.

6 min read28 views
AgricultureCannabisGhanaLicensingMedicinal use

Ghana has officially legalized cannabis farming for both industrial and medicinal purposes after lawmakers ratified a policy framework that allows licensed companies to produce the crop under regulations.

This significant decision comes after the Ghanaian Parliament passed essential legislative measures that enable the government to implement a licensing system for businesses interested in cannabis cultivation and processing, adhering to specific regulatory frameworks.

Image depicting cannabis plants for cultivation

The focus of the new policy is on cultivating cannabis strains with low levels of tetrahydrocannabinol (THC), which are specifically designated for manufacturing pharmaceuticals, producing fibers, and other industrial usages.

Companies intending to operate in this sector must apply for formal licenses and adhere to strict regulations concerning cultivation, security, processing, and export standards.

Government representatives have indicated this initiative is designed to position Ghana as a significant player in the expanding global cannabis market, emphasizing rigorous oversight to avert potential abuses or diversion into illegal activities.

This legalization is also anticipated to generate fresh investment opportunities, draw foreign investments, and generate jobs across agriculture, pharmaceutical, and manufacturing industries.

Officials have announced that the licensing phase will commence shortly, with regulators ready to accept applications from qualified enterprises aiming to join the nascent legal cannabis sector.

Stay connected with us:

Comments (0)

You must be logged in to comment.

Be the first to comment on this article!